(Q46316392)

21 December 2017

title

Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest (English)

1 reference

21 December 2017

main subject

hepatocellular carcinoma

1 reference

Jian Fan

1

1 reference

21 December 2017

Bin Lou

2

1 reference

21 December 2017

Wei Chen

3

1 reference

21 December 2017

Jie Zhang

4

1 reference

21 December 2017

Sha Lin

5

1 reference

21 December 2017

Fei-fei Lv

6

1 reference

21 December 2017

Yu Chen

7

1 reference

21 December 2017

publication date

17 August 2014

1 reference

21 December 2017

published in

Tumor Biology

1 reference

21 December 2017

volume

35

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

11523-11532

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s13277-014-2358-2

exact match

0 references

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

An intact immune system is required for the anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

HDAC4 promotes growth of colon cancer cells via repression of p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

The role of histone deacetylase 7 (HDAC7) in cancer cell proliferation: regulation on c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Receptor-independent protein kinase C alpha (PKCalpha) signaling by calpain-generated free catalytic domains induces HDAC5 nuclear export and regulates cardiac transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

HDAC inhibition synergistically enhances alkylator-induced DNA damage responses and apoptosis in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

An apoptosis targeted stimulus with nanosecond pulsed electric fields (nsPEFs) in E4 squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

tRNA traffic meets a cell-cycle checkpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

The role of histone deacetylases (HDACs) in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Histone deacetylase as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Histone deacetylase inhibitors as new cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

USP10 regulates p53 localization and stability by deubiquitinating p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2358-2

Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells

21 January 2018

1 reference

12 December 2020

Improved radiosensitizing effect of the combination of etanidazole and paclitaxel for hepatocellular carcinoma in vivo

1 reference

12 December 2020

p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species

1 reference

12 December 2020

Effects of varicocelectomy on sperm DNA fragmentation, mitochondrial function, chromatin condensation, and apoptosis

1 reference

12 December 2020

Loss of heterochromatin protein 1 gamma reduces the number of primordial germ cells via impaired cell cycle progression in mice

1 reference

12 December 2020

Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury

1 reference

12 December 2020

10.1007/S13277-014-2358-2

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017